Design and in vivo evaluation of oxycodone once-a-day controlled-release tablets - Wikidata - awgldk - TriplyDB

Design and in vivo evaluation of oxycodone once-a-day controlled-release tablets

Design and in vivo evaluation of oxycodone once-a-day controlled-release tablets

http://www.wikidata.org/entity/Q35066646

about

Slow drug delivery decreased total body clearance and altered bioavailability of immediate- and controlled-release oxycodone formulations

P2860

Q38762087-1A93430E-7F33-4561-B755-2DBF517BCAAD

P2860

Design and in vivo evaluation of oxycodone once-a-day controlled-release tablets

http://www.wikidata.org/entity/Q35066646

description

2015 nî lūn-bûn

@nan

2015 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2015 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

name

Design and in vivo evaluation of oxycodone once-a-day controlled-release tablets

@ast

Design and in vivo evaluation of oxycodone once-a-day controlled-release tablets

@en

type

label

Design and in vivo evaluation of oxycodone once-a-day controlled-release tablets

@ast

Design and in vivo evaluation of oxycodone once-a-day controlled-release tablets

@en

prefLabel

Design and in vivo evaluation of oxycodone once-a-day controlled-release tablets

@ast

Design and in vivo evaluation of oxycodone once-a-day controlled-release tablets

@en

P1433

Q35066646-EDC3136C-4DB4-4F28-A732-F058B6F10695

P1476

Q35066646-66D05093-7CD0-4594-BCFA-E53A396109A8

P2093

Q35066646-1AC0C1C3-8A0F-462E-8D00-EEEE3CA5DCD1

Q35066646-38775D4A-3112-4EAD-AF4F-E9B505DD200C

Q35066646-69CDAFE1-4CEE-42FE-A67A-E7BA8F7D4F59

Q35066646-807E4166-97CA-4DA2-9C45-BEFE21C00819

Q35066646-C763B105-92E4-403E-A855-88672508C888

Q35066646-C82E0C38-66F3-4796-9D21-D1E53123AFC1

Q35066646-D08C069F-50B4-4A2E-A883-A81200A92E3D

Q35066646-DD8C3216-8318-43B7-B3AF-35AC6D0E91D3

Q35066646-E493BAD0-8327-48B3-9314-29990368F350

P2860

Q35066646-204E6E79-48AA-4D24-8971-52F986EC3F89

Q35066646-34679C62-0C0B-4DB5-ABCA-F3A8C9A62D57

Q35066646-3EA54AF5-8BFF-4506-B058-4382F2AC8B13

Q35066646-3F21697A-5CED-46E5-9092-225C2CDBBEFC

Q35066646-53773F08-6505-4296-8435-EC9CE6532490

Q35066646-78493B6B-DE99-42AB-9CA7-28902688F61A

Q35066646-7E4DB808-0763-4F60-BB5C-009A348562A3

Q35066646-8305190F-433D-447B-91C1-372875E28F93

Q35066646-87D5F84E-F858-4739-B18A-D24748E707D5

Q35066646-94992B58-CD52-4C33-B4A2-7A25E2A6FBDF

P304

Q35066646-7E0BB51C-AF5E-47A5-AAD6-5ED3A6FF8E04

P31

Q35066646-AEDFDD5B-7713-455C-BF6E-83DBA95CD353

P356

Q35066646-C1F44F32-443E-43BB-9E9D-CF436D80838A

P407

Q35066646-5A0CDFC4-DA61-4F90-88EF-E5C051CE555F

P478

Q35066646-D4AE3ACA-B3C6-441B-8AA2-7275627F3CA5

P577

Q35066646-F99D3F2E-B6AA-4DD9-AA38-79BAEA420A67

P698

Q35066646-40CFA535-A863-4C89-A93B-2EDD21346CE6

P932

Q35066646-F84D2607-7FBB-4052-8D59-BF881DBBF73E

P356

P1433

Drug Design, Development and Therapy

P1476

Design and in vivo evaluation of oxycodone once-a-day controlled-release tablets

@en

P2093

Chun-Woong Park

http://www.w3.org/2001/XMLSchema#string

Dong-Wook Kim

http://www.w3.org/2001/XMLSchema#string

Eun-Seok Park

http://www.w3.org/2001/XMLSchema#string

Jeong-Woong Seo

http://www.w3.org/2001/XMLSchema#string

Ju-Young Kim

http://www.w3.org/2001/XMLSchema#string

Junsang Park

http://www.w3.org/2001/XMLSchema#string

Moonseok Lee

http://www.w3.org/2001/XMLSchema#string

Sung-Hoon Lee

http://www.w3.org/2001/XMLSchema#string

Yun-Seok Rhee

http://www.w3.org/2001/XMLSchema#string

P2860

Analgesic efficacy of controlled-release oxycodone in postoperative pain.

A flexible technology for modified release of drugs: multi layered tablets.

OROS® hydromorphone in chronic pain management: when drug delivery technology matches clinical needs.

Water distribution studies within cellulose ethers using differential scanning calorimetry. 2. Effect of polymer substitution type and drug addition.

Relative potency of controlled-release oxycodone and controlled-release morphine in a postoperative pain model.

Pharmacokinetics and pharmacodynamics of oxycodone when given intravenously and rectally to adult patients with cancer pain.

Dose-ranging study of oxycodone for chronic pain in advanced cancer.

Single-dose and steady-state pharmacokinetics and pharmacodynamics of oxycodone in patients with cancer.

Intravenous morphine and oxycodone for pain after abdominal surgery.

HPMC-matrices for controlled drug delivery: a new model combining diffusion, swelling, and dissolution mechanisms and predicting the release kinetics.

P304

695-706

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2147/DDDT.S77356

http://www.w3.org/2001/XMLSchema#string

P407

P478

9

http://www.w3.org/2001/XMLSchema#string

P577

2015-01-30T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

25678774

http://www.w3.org/2001/XMLSchema#string

P932

4322610

http://www.w3.org/2001/XMLSchema#string